Beam Therapeutics, Inc. (BEAM)
25.75
+0.05
(+0.19%)
USD |
NASDAQ |
Oct 12, 11:15
Beam Therapeutics Free Cash Flow (Quarterly) : -68.51M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -68.51M |
| March 31, 2026 | -130.74M |
| December 31, 2025 | -87.02M |
| September 30, 2025 | -86.49M |
| June 30, 2025 | -79.59M |
| March 31, 2025 | -106.95M |
| December 31, 2024 | -79.34M |
| September 30, 2024 | -89.70M |
| June 30, 2024 | -84.97M |
| March 31, 2024 | -102.18M |
| December 31, 2023 | 131.48M |
| September 30, 2023 | -97.73M |
| June 30, 2023 | -100.85M |
| March 31, 2023 | -115.83M |
| December 31, 2022 | -77.45M |
| September 30, 2022 | -86.28M |
| Date | Value |
|---|---|
| June 30, 2022 | -73.92M |
| March 31, 2022 | 211.23M |
| December 31, 2021 | -11.54M |
| September 30, 2021 | -2.773M |
| June 30, 2021 | -48.71M |
| March 31, 2021 | -50.06M |
| December 31, 2020 | -32.42M |
| September 30, 2020 | -24.03M |
| June 30, 2020 | -25.20M |
| March 31, 2020 | -30.44M |
| December 31, 2019 | -19.96M |
| September 30, 2019 | -18.41M |
| June 30, 2019 | -17.94M |
| March 31, 2019 | -28.21M |
| December 31, 2018 | -14.19M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Prime Medicine, Inc. | -41.09M |
| Intellia Therapeutics, Inc. | -84.92M |
| Twist Bioscience Corp. | -8.648M |
| Q32 Bio, Inc. | -3.075M |
| Sarepta Therapeutics, Inc. | 196.52M |